Are There Clinically Significant Differences Among the Third Generation EGFR Inhibitors? episode artwork

EPISODE · Dec 12, 2015 · 3 MIN

Are There Clinically Significant Differences Among the Third Generation EGFR Inhibitors?

from GRACEcast · host cancerGRACE Meetings

Drs. Ben Solomon, Leora Horn, & Jack West compare the clinical data with the third generation EGFR TKIs so active in acquired resistance and consider whether there are significant differences between them.

Episode metadata supplied by the publisher feed · Published Dec 12, 2015

Embed this episode

NOW PLAYING

Are There Clinically Significant Differences Among the Third Generation EGFR Inhibitors?

0:00 3:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 3 minutes long.

When was this GRACEcast episode published?

This episode was published on December 12, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!